Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Clindamycin Phosphate Injection
Status: Currently in Shortage
»Date first posted:
03/21/2023
»Therapeutic Categories: Anti-Infective
Baxter Healthcare (Reverified 04/17/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50) | Available | ||
| Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50) | Limited Availability | Recovery April 2024 | Delay in shipping of the drug |
| Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50) | Limited Availability | Recovery April 2024 | Delay in shipping of the drug |
| Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50) | Available | ||
| Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50) | Available | ||
| Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50) | Available |
Pfizer Inc. (Revised 04/18/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Cleocin Phosphate, Injection, 150 mg/1 mL (NDC 0009-0870-26) | Limited Availability | Limited Supply Available. Next Delivery and Estimated Recovery: June 2024 | Demand increase for the drug |
| Cleocin Phosphate, Injection, 150 mg/1 mL (NDC 0009-0775-26) | Unavailable | Next Delivery: June 2024; Estimated Recovery: September 2024; Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
| Cleocin Phosphate, Injection, 150 mg/1 mL (NDC 0009-0728-09) | Available | ||
| Cleocin Phosphate, Injection, 150 mg/1 mL (NDC 0009-0902-18) | Limited Availability | Limited Supply Available. Next Delivery: April 2024; Estimated Recovery: June 2024 | Demand increase for the drug |
| Cleocin Phosphate, Injection, 150 mg/1 mL (NDC 0009-3051-02) | Available | ||
| Cleocin Phosphate, Injection, 150 mg/1 mL (NDC 0009-5095-06) | Unavailable | Next Delivery: April 2024; Estimated Recovery: June 2024 | Demand increase for the drug |
| Cleocin Phosphate, Injection, 150 mg/1 mL (NDC 0009-4073-04) | Available |
Sagent Pharmaceuticals (Revised 03/06/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 150 mg/1 mL (NDC 25021-115-02) | Unavailable | Backorder. Estimated availability TBD | Demand increase for the drug |
| Injection, 150 mg/1 mL (NDC 25021-115-04) | Unavailable | Backorder. Estimated availability TBD | Demand increase for the drug |
| Injection, 150 mg/1 mL (NDC 25021-115-06) | Unavailable | Backorder. Estimated availability TBD | Demand increase for the drug |
Sandoz Inc. (Reverified 04/08/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09) | Limited Availability | Demand increase for the drug | |
| Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09) | Available | ||
| Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09) | Available | ||
| Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24) | Unavailable | Resupply April 2024; Civica Label | Demand increase for the drug |
| Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24) | Unavailable | Resupply April 2024; Civica Label | Demand increase for the drug |